DiaMedica Therapeutics Inc.
DMAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,025 | $4,543 | $4,728 | $4,707 |
| Short-Term Investments | $41,122 | $48,352 | $28,774 | $40,405 |
| Receivables | $236 | $369 | $82 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $227 | $411 | $251 | $327 |
| Total Curr. Assets | $44,610 | $53,675 | $33,835 | $45,439 |
| Property Plant & Equip (Net) | $427 | $485 | $560 | $112 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,308 | $0 | $0 | $0 |
| Total NC Assets | $1,735 | $485 | $560 | $112 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $46,345 | $54,160 | $34,395 | $45,551 |
| Liabilities | – | – | – | – |
| Payables | $940 | $926 | $734 | $509 |
| Short-Term Debt | $103 | $83 | $69 | $49 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,347 | $1,777 | $1,365 | $966 |
| Total Curr. Liab. | $5,390 | $2,786 | $2,168 | $1,524 |
| LT Debt | $237 | $317 | $400 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $237 | $317 | $400 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $340 | $400 | $469 | $52 |
| Total Liabilities | $5,627 | $3,103 | $2,568 | $1,527 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$140,002 | -$115,558 | -$96,177 | -$82,501 |
| AOCI | $23 | $6 | -$74 | -$51 |
| Other Equity | $180,697 | $166,609 | $128,078 | $126,576 |
| Total Equity | $40,718 | $51,057 | $31,827 | $44,024 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $46,345 | $54,160 | $34,395 | $45,551 |
| Net Debt | -$2,685 | -$4,143 | -$4,259 | -$4,655 |